Publications

The emerging field of bioelectronic medicine (BEM) is poised to make a significant impact on the treatment of several neurological and inflammatory disorders. With several BEM therapies being recently approved for clinical use and others in late-phase clinical trials, the 2022 BEM summit was a timely scientific meeting convening a wide range of experts to discuss the latest developments in the field. The BEM Summit was held over two days in New York with more than thirty-five invited speakers and panelists comprised of researchers and experts from both academia and industry. The goal of the meeting was to bring international leaders together to discuss advances and cultivate collaborations in this emerging field that incorporates aspects of neuroscience, physiology, molecular medicine, engineering, and technology. This Meeting Report recaps the latest findings discussed at the Meeting and summarizes the main developments in this rapidly advancing interdisciplinary field.

The fourth bioelectronic medicine summit 'Technology Targeting Molecular Mechanisms' took place on September 23 and 24, 2020, as a virtual meeting hosted by the Feinstein Institutes for Medical Research, Northwell Health. The summit called international attention to Bioelectronic Medicine as a platform for new developments in science, technology, and healthcare, and served as an arena for exchanging new ideas and seeding potential collaborations involving teams in academia and industry. Key advances discussed included innovations in bioelectronic limbs and prostheses, wearable and injectable sensors in paralysis and spinal cord injury, and brain stimulation for the blind including visual cortical prosthetics. Artificial intelligence is becoming a vital component of bioelectronic medicine with implications in neuroscience, cardiology, and many other clinical fields.